Jacobs Levy Equity Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-113,436
| Closed | -$1.38M | – | 1111 |
|
|
2020
Q3 | $1.38M | Sell |
113,436
-10,542
| -9% | -$128K | 0.01% | 593 |
|
|
2020
Q2 | $1.43M | Buy |
123,978
+17,788
| +17% | +$205K | 0.02% | 592 |
|
|
2020
Q1 | $1.46M | Buy |
106,190
+722
| +0.7% | +$9.89K | 0.02% | 544 |
|
|
2019
Q4 | $622K | Buy |
105,468
+54,312
| +106% | +$320K | 0.01% | 757 |
|
|
2019
Q3 | $271K | Buy |
51,156
+31,049
| +154% | +$164K | ﹤0.01% | 796 |
|
|
2019
Q2 | $155K | Sell |
20,107
-54,763
| -73% | -$422K | ﹤0.01% | 897 |
|
|
2019
Q1 | $1.49M | Buy |
74,870
+29,040
| +63% | +$578K | 0.02% | 573 |
|
|
2018
Q4 | $605K | Sell |
45,830
-2,030
| -4% | -$26.8K | 0.01% | 705 |
|
|
2018
Q3 | $1.76M | Buy |
47,860
+8,424
| +21% | +$310K | 0.03% | 544 |
|
|
2018
Q2 | $1.38M | Buy |
+39,436
| New | +$1.38M | 0.02% | 586 |
|
|
2018
Q1 | – | Sell |
-11,130
| Closed | -$417K | – | 1084 |
|
|
2017
Q4 | $417K | Buy |
11,130
+7,620
| +217% | +$285K | 0.01% | 787 |
|
|
2017
Q3 | $187K | Buy |
3,510
+470
| +15% | +$25K | ﹤0.01% | 876 |
|
|
2017
Q2 | $173K | Buy |
+3,040
| New | +$173K | ﹤0.01% | 860 |
|
|
2016
Q4 | – | Sell |
-3,142
| Closed | -$195K | – | 1080 |
|
|
2016
Q3 | $195K | Sell |
3,142
-5,058
| -62% | -$314K | ﹤0.01% | 914 |
|
|
2016
Q2 | $464K | Sell |
8,200
-1,424
| -15% | -$80.6K | 0.01% | 777 |
|
|
2016
Q1 | $616K | Buy |
+9,624
| New | +$616K | 0.01% | 684 |
|